Found 14 matching trials
Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor
PHASE2The folate receptor is over-expressed on many types of cancer cells and new...
Location
Multiple Locations
A Study of FolateScan in Patients With Knee Osteoarthritis
N/AThe purpose of this study is to evaluate 99mTc - EC20 imaging (FolateScan),...
Location
Duke University Medical Center
Study of EC0489 for the Treatment of Refractory or Metastatic Tumors
PHASE1This is a Phase 1 clinical trial evaluating the safety and tolerability of ...
Location
Horizon Oncology Center
Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients
PHASE1Open-label, single-center, single-treatment group, baseline-controlled (for...
Location
Washington University Medical Center
Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
PHASE2Phase 2, multi-center, open-label, single-treatment group, baseline-control...
Study of EC0225 for the Treatment of Refractory or Metastatic Tumors
PHASE1This is a Phase 1 clinical trial evaluating the safety and tolerability of ...
Location
Greenebaum Cancer Center - University of Maryland Medicine
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma
PHASE2The folate receptor (FR) is overexpressed by many different cancer types, i...
Location
Baylor College of Medicine
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
PHASE1Phase 1A/B, multicenter, open-label, non-randomized, dose-escalation oncolo...
An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery
PHASE1This study looks to enroll subjects with ovarian cancer who will be having ...
Location
Levine Cancer Institute-Concord/Clinical Trials
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
PHASE2Many types of cancers overexpress a receptor for the vitamin folate (Folate...